Peptide Schedule
Vladonix6 residuesAEDLVGEach bubble = one amino acid. Size = residue mass. Color = chemical class.

Vladonix Dosage Calculator

ImmuneOralResearchUnknown half-life

Vladonix is a natural thymus peptide bioregulator developed by Professor Vladimir Khavinson at the St.

Normalizes T-cell counts and CD4/CD8 ratios in clinical observationsSupports thymus gland function during age-related immune declineOral capsule — no injections or reconstitution requiredShort treatment courses with effects persisting for months4 weeks on / 12 weeks off

10mcg · Daily

100500
0.0 units
100 units (1mL)
Concentration
0
mcg/mL
Draw Volume
< 0.001
mL
Syringe Units
< 0.1
units
Doses / Vial
0
doses

Summary: Add 0mL BAC water to your 20mg vial. Draw to < 0.1 units on a U-100 syringe for a 10mcg dose. This vial will last 0 doses.

Cycle Planner

Oral. Typical beginner frequency: daily.

Vladonix Pharmacokinetics

Vladonix Dosing Protocol

LevelDose / InjectionFrequency
Beginner10mgDaily
Moderate20mg2x Daily
Aggressive20mg3x Daily

Note: Thymus peptide bioregulator from the Khavinson line. Contains peptide complex A-6 derived from calf thymus. Standard protocol is 1-2 capsules daily for 30 days, repeated every 3-6 months. Oral capsule — no reconstitution needed.

About Vladonix

Vladonix is a natural thymus peptide bioregulator developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It contains peptide complex A-6, a mixture of low-molecular-weight peptides (under 10 kDa) extracted from the thymus glands of young calves. The product targets thymic tissue to support T-cell maturation and restore age-related immune decline. In a clinical study of 42 patients aged 34-65, Vladonix normalized impaired immune parameters in 78% of cases. The strongest effects were seen in T-lymphocyte subpopulations — CD3+ and CD4+ counts increased reliably, and the CD4+/CD8+ ratio returned to normal ranges. B-cell parameters showed more modest changes. Vladonix isn't a single defined peptide like Thymosin Alpha 1. It's a complex extract containing multiple short peptides that are thought to interact with DNA promoter regions in immune cells, influencing gene expression tied to T-cell differentiation and cytokine balance. This mechanism is consistent with Khavinson's broader bioregulation theory, where tissue-specific peptides act as epigenetic modulators. The product has been used in Russian clinical practice alongside other Khavinson bioregulators for over two decades. It's taken orally as capsules, doesn't require injection, and has shown no reported side effects or drug dependence in clinical observations. Evidence remains limited to Russian and Eastern European studies, and it hasn't undergone Western regulatory review.

Frequently Asked Questions